"TBSF" (20%) Human Albumin Solution

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

Albumin, Quantity: 200 g/L

Fáanlegur frá:

CSL Behring Australia Pty Ltd

INN (Alþjóðlegt nafn):

Albumin

Lyfjaform:

Injection, solution

Samsetning:

Excipient Ingredients: octanoate; sodium

Stjórnsýsluleið:

Intravenous

Einingar í pakka:

50mL, 100mL

Tegund:

Medicine Listed (Export Only)

Gerð lyfseðils:

(S1) This Schedule is intentionally blank

Ábendingar:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Vörulýsing:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Leyfisstaða:

Listed (Export Only)

Leyfisdagur:

2006-03-01